Published 8 months ago • loading... • Updated 8 months ago
Finger prick blood test trial 'could revolutionise' Alzheimer's diagnosis, say experts
The Bio-Hermes-002 trial enrolls 1,000 volunteers to test a finger-prick blood method detecting three Alzheimer’s biomarkers for earlier, less invasive diagnosis than current standards.
A study involving 1,000 people aged over 60 aims to detect Alzheimer's disease biomarkers through a finger-prick blood test.
The study participant Dr Michael Sandberg, whose mother had Alzheimer's, was encouraged to take part after witnessing her decline.
Experts say early and accurate diagnosis must be a priority for the NHS with new Alzheimer's treatments on the horizon.